The AABB website is currently experiencing technical issues related to login and SSO. Thank you for your patience as we work to get this resolved. If you need immediate assistance, please contact us.
Product Code: CT_CERT_16703502
The AABB Cellular Therapies (CT) Certificate Program gives individuals a solid foundation on scientific, operational and regulatory topics relevant to working in the field. Developed by faculty experts and offered via a series of instructional modules at an introductory to intermediate level, this web-based program is presented entirely online as independent, self-paced study through a learning management system called Blackboard. Upon purchase, the student will receive application and enrollment information. Enrollment cycles start on the first of each month for those that complete the application process by the required deadline of the preceding month. Details are provided in the FAQs.
Upon completion of all of the 12 modules, the learner will have acquired a solid foundation of the scientific principles, operational issues and regulatory framework to enhance experience and practical knowledge relevant to active participation in and employment within the cellular therapy field. A certificate will be conferred when the learner has met all of requirements listed below.
Program Format and Registration Process
Modules are designed to emphasize topics that are important to functioning in a laboratory/processing environment or facility providing background on the science, processing and manufacturing of cells, potential for product scale up, and regulatory issues in this evolving field.
Requirements
Learning Objectives
Upon successful completion of the program, the learner will be able to:
AABB is now the Association for the Advancement of Blood & Biotherapies. Learn more about our new name and brand – and watch as we evolve throughout 2022.
©2020 AABB. All Rights Reserved.
4550 Montgomery Avenue, Suite 700, North Tower, Bethesda, MD 20814
Phone: 301.907.6977 | Fax: 301.907.6895
Web Design and Development by Matrix Group International, Inc.